Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SUPER MICRO COMPUTER, INC. (SMCI)

  • Business News
  • June 02, 2026, 13:13 UTC
  • 1
  • 1 comments

Supermicro werkt samen met Arm aan een nieuwe klasse energie-efficiënte rackschaal-infrastructuur voor Enterprise Agentic AI USA - Nederlands India - English USA - English BRAZIL - Portuguese

Market reaction Comment Full text

Oncolytics Biotech Inc (ONCY)

  • Business News
  • June 02, 2026, 13:12 UTC
  • 2
  • 1 comments

A New Press Release from Oncolytics Biotech, Inc

Market reaction Comment Full text

T-MOBILE US, INC. (TMUS)

  • Business News
  • June 02, 2026, 13:12 UTC
  • 2
  • 1 comments

T-Mobile Ushers In a New Era of Membership with Its Biggest Celebration Yet

Market reaction Comment Full text

SNOWFLAKE INC. (SNOW)

  • Business News
  • June 02, 2026, 13:10 UTC
  • 2
  • 1 comments

Thomson Reuters Powers Trusted Enterprise AI at Scale on Snowflake

Market reaction Comment Full text

AEROVIRONMENT INC (AVAV)

  • Business News
  • June 02, 2026, 13:10 UTC
  • 2
  • 1 comments

AV to Expand Advanced Production Capabilities in Dayton Area

Market reaction Comment Full text

SNOWFLAKE INC. (SNOW)

  • Business News
  • June 02, 2026, 13:08 UTC
  • 2
  • 1 comments

Sanofi Chooses Snowflake to Accelerate its AI-Powered Drug Development

Market reaction Comment Full text

T-MOBILE US, INC. (TMUS)

  • Business News
  • June 02, 2026, 13:08 UTC
  • 2
  • 1 comments

T-Mobile da comienzo a una nueva era de membresía celebrando a lo grande

Market reaction Comment Full text

GREIF, INC (GEF)

  • Business News
  • June 02, 2026, 13:07 UTC
  • 4
  • 1 comments

Greif, Inc. Declares 10.7% Increase to Quarterly Dividend

Market reaction Comment Full text

enVVeno Medical Corp (NVNO)

  • Business News
  • June 02, 2026, 13:06 UTC
  • 4
  • 1 comments

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series

Market reaction Comment Full text

CARDIFF ONCOLOGY, INC. (CRDF)

  • Business News
  • June 02, 2026, 13:06 UTC
  • 4
  • 1 comments

Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting

Market reaction Comment Full text
  • Previous
  • 1197
  • 1198
  • 1199
  • 1200
  • 1201
  • Next

Search

News categories

  • Technical Exchange News(13393)
  • Event(6229)
  • SEC News(343323)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(189857)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin